Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2001

[Federal Register: May 30, 2001 (Volume 66, Number 104)] [Notices] [Page 29344] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr30my01-86]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 27, 2000, Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug Schedule
Tetrahydrocannabinols (7370) I
Dihydromorphine (9145) I
Amphetamine (1100) II
Methylphenidate (1724) II
Cocaine (9041) II
Codeine (9050) II
Diprenorphine (9058) II
Etorphine Hydrochloride (9059) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Hydrocodone (9193) II
Levorphanol (9220) II
Meperidine (9230) II
Methadone (9250) II
Methadone-intermediate (9254) II
Dextropopoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Thebaine (9333) II
Opium extracts (9610) II
Opium fluid extract (9620) II
Opium tincture (9630) II
Opium powdered (9639) II
Opium granulated (9640) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Noroxymorphone (9668) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The firm plans to manufacture the controlled substances for distribution as bulk products to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration. 

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than July 30, 2001.

Dated: May 14, 2001.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 01-13446 Filed 5-29-01; 8:45 am]

BILLING CODE 4410-09-M

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility